PridCor Therapeutics

Funding and NIH signals

• SEC Form D raise Filed a Form D for an offering of up to $6.05M, no sales reported yet (filed May 8, 2026; amended Jul 6, 2026); +1 other Form D filing in the last 12 months. SEC Form D 0002074593-26-000002 (May 8, 2026)
  Evidence (2 events)

  • May 8, 2026 · SEC Form D 0002074593-26-000002
    Name of Issuer: PridCor Therapeutics, LLC; CIK: 2074593; Address: Tuscaloosa, AL; Submission type: D; Filing date: 2026-05-08; Industry Group: Pharmaceuticals; Date of First Sale: Yet to Occur; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 6045000; Total Amount Sold: 0; Federal exemptions: 06c || Name of Issuer: PridCor Therapeutics, LLC; CIK: 2074593; Address: Tuscaloosa, AL; Submission type: D/A; Filing date: 2026-07-06; Industry Group: Pharmaceuticals; Date of First Sale: Yet to Occur; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 6045000; Total Amount Sold: 0; Federal exemptions: 06b
  • Feb 2, 2026 · SEC Form D 0002074593-26-000001
    Name of Issuer: PridCor Therapeutics, LLC; CIK: 2074593; Address: Tuscaloosa, AL; Submission type: D; Filing date: 2026-02-02; Industry Group: Pharmaceuticals; Date of First Sale: Yet to Occur; Types of Securities Offered: Debt, Security to be acquired; Business combination transaction: false; Total Offering Amount: 1000000; Total Amount Sold: 0; Federal exemptions: 06c

Job counts as of Oct 18, 2026. All funding and NIH signals